Adult-onset mitochondrial movement disorders: a national picture from the Italian Network
Authors:
Open Access
- 14 July 2021
- journal article
- research article
- Published by Springer Nature in Journal of Neurology
- Vol. 269 (3) , 1413-1421
Abstract
Introduction: Both prevalence and clinical features of the various movement disorders in adults with primary mitochondrial diseases are unknown. Methods: Based on the database of the “Nation-wide Italian Collaborative Network of Mitochondrial Diseases”, we reviewed the clinical, genetic, neuroimaging and neurophysiological data of adult patients with primary mitochondrial diseases (n = 764) where ataxia, myoclonus or other movement disorders were part of the clinical phenotype. Results: Ataxia, myoclonus and movement disorders were present in 105/764 adults (13.7%), with the onset coinciding or preceding the diagnosis of the mitochondrial disease in 49/105 (46.7%). Ataxia and parkinsonism were the most represented, with an overall prevalence at last follow-up of 59.1% and 30.5%, respectively. Hyperkinetic movement disorders were reported in 15.3% at last follow-up, being the less common reported movement disorders. The pathogenic m.8344A > G and POLG variants were always associated with a movement disorder, while LHON variants and mtDNA single deletions were more commonly found in the subjects who did not present a movement disorder. The most common neuroimaging features were cortical and/or cerebellar atrophy, white matter hyperintensities, basal ganglia abnormalities and nigro-striatal degeneration. Almost 70% of patients with parkinsonism responded to dopaminergic therapy, mainly levodopa, and 50% with myoclonus were successfully treated with levetiracetam. Conclusion: Movement disorders, mainly ataxia and parkinsonism, are important findings in adult primary mitochondrial diseases. This study underlies the importance of looking for a mitochondrial etiology in the diagnostic flowchart of a movement disorder and may help direct genetic screening in daily practice.Keywords
Funding Information
- Fondazione Telethon (GSP16001, GUP09004)
- EJPRD (GENOMIT)
- Ministero della Salute (RF-2016-02361495)
- Regione Emilia-Romagna (ER-MITO)
- Università di Pisa
This publication has 34 references indexed in Scilit:
- POLG1-related levodopa-responsive parkinsonismClinical Neurology and Neurosurgery, 2014
- Phenotypic heterogeneity of the 8344A>G mtDNA “MERRF” mutationNeurology, 2013
- Phenomenology and classification of dystonia: A consensus updateMovement Disorders, 2013
- Severe nigrostriatal degeneration without clinical parkinsonism in patients with polymerase gamma mutationsBrain, 2013
- Cerebellar Ataxia in Patients With Mitochondrial DNA DiseaseJournal of Neuropathology & Experimental Neurology, 2012
- Classification of movement disordersMovement Disorders, 2011
- Multinuclear Magnetic Resonance Spectroscopy for in Vivo Assessment of Mitochondrial Dysfunction in Parkinson's DiseaseAnnals of the New York Academy of Sciences, 2008
- Two novel POLG1 mutations in a patient with progressive external ophthalmoplegia, levodopa-responsive pseudo-orthostatic tremor and parkinsonismNeuromuscular Disorders, 2008
- Antimyoclonic effect of levetiracetam in MERRF syndromeJournal of the Neurological Sciences, 2006
- Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.Journal of Neurology, Neurosurgery & Psychiatry, 1992